cer. which amount will decrease with age to a

cer. which amount will decrease with age to a minimum of $ 17,500 if the Exposed Person is 85 years or older. An Exposed Person may collect separately for (a), (b) and (c) above, so that the maximum payment to an Exposed Person is $410,000. The cash payments described above will be reduced by 12.5% if the Exposed Person had smoked in the five years prior to diagnosis. A separate 12.5% reduction will be made if he or she had failed to participate in the health screening program in each of the three years prior to diagnosis (or in each year that the program was available, if less than three years). The DCA Fund also will pay $1,000 to any Exposed Person who was diagnosed with hemorrhagic cystitis within three months following exposure (this is a one-time payment regardless of the number of manifestations). In addition, the DCA Fund will pay for administrative costs, and class counsel's attorney s' fees, costs and expenses as determined - by the Court. All cash payments from the DCA Fund are paid only on account of a compensable claim of an Exposed Person, i.e.. an eligible Plant Worker. Formulator, Applicator or Other Covered Worker, as defined in this Notice. Cash payments to a spouse, parent, child or other relative will only be made if they are the legal representative of an Exposed Person.

The benefits of the DCA Fund w ill continue as long as the MMT Fund continues, or until the DCA Fund is exhausted as set forth below. Ciba-Geigy has agreed to pay up to a maximum of $45.(XK).(XK) for the benefits afforded by that Fund: If the DCA Fund is exhausted. Ciba-Geigy may continue paying for compensable claims. If Cibl-Geigy does not continue to pay. Settlement Class Members w ill be able to opt-out of the DCA Fund and will regain their right to pursue any legal claims they may have, except for claims for medical monitoring, medical treatment, fear of illness or cancer, or increased risk of illness or cancer, because medical monitoring and treatment will continue, to be available

(3) Other Conditions. The Stipulation of Settlement presemlv provides for medical monitoring, treatment and compensation payments for certain medical conditions set forth in this Notice. In the event, however, that a Court approved Epidemiology Panel determines to a reasonable medical certainly that any other medical condition is caused by Galecron® exposure, that condition will be deemed a compensable claim, and will be eligible for medical monitoring (if feasible): medical treatment; and cash pay ments. The cash pay ments will not exceed the maximum amounts payable for the covered medical conditions set forth above

(4) Administrator. A nationally recognized entity or entities with substantial investment and medical claims administration experience will be appointed by the Court to administer the Settlement. The Administrator will determine whether a Settlement Class Member is eligible for benefits under the settlement. Any disputes concerning a Settlement Class Member's entitlement to benefits will be resolved by a Medical Advisors Panel or by a single arbitrator, depending upon the issue in dispute. The decision of the Medical Adv isory Panel or arbitrator each (lave the effect of an arbitration decision and shall be binding upon all parties, including the Settlement Class Member

(5) .Release Settlement Class Members who do not exclude themselves from the Class release all past, present and future claims: (i) relating to the covered medical conditions listed above: and liil relating to an Exposed Person's exposure to Galecron®. including all claims alleging that any other cancers, personal injuries or risks are caused by exposure to Galecron®. This mean. that claims that Galecron® exposure caused any condition other than those medical conditions listed above will be released, but will receive no compensation or treatment, unless the Court approved Epidemiology Panel finds that such other condition is caused by Galecron® exposure. The release is effective as against Ciba-Geigy and certain additional releasees as defined in the Stipulation of Settlement, including Ciba-Geigy. Ltd., the parent of Ciba-Geigy.

If you believe you are a member of the Settlement Class, and have any questions regarding any of the benefits set forth above, you are urged to call 1-800-565-3126 for further information. '